๐Ÿ‡บ๐Ÿ‡ธ Enjoin Reports 923% Average ROI Delivered in Q1 2026

๐Ÿ‡บ๐Ÿ‡ธ

Enjoin announced that its clinically intelligent, physician-directed chart review programs delivered a 923% ROI in Q1 2026.

Source: globenewswire

Country: United States